Hrt Financial LP Acadia Pharmaceuticals Inc Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Hrt Financial LP holds 52,368 shares of ACAD stock, worth $852,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,368

Previous 175,819 70.21%

Holding current value

$852,027

Previous $2.86 Million 71.82%

% of portfolio

0.0%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$15.14 - $19.14 $1.87 Million - $2.36 Million	-123,451 Reduced 70.21%	52,368 $805,000
Q2 2024 Aug 12, 2024	BUY	$14.62 - $18.42 $2.07 Million - $2.61 Million	141,756 Added 416.16%	175,819 $2.86 Million
Q1 2024 May 13, 2024	SELL	$17.79 - $30.86 $4.92 Million - $8.53 Million	-276,499 Reduced 89.03%	34,063 $629,000
Q4 2023 Feb 09, 2024	BUY	$20.78 - $31.77 $5.84 Million - $8.93 Million	281,165 Added 956.44%	310,562 $9.72 Million
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $612,633 - $983,917	29,397 New	29,397 $612,000
Q1 2023 May 12, 2023	BUY	$16.32 - $20.92 $4.2 Million - $5.38 Million	257,237 New	257,237 $4.84 Million
Q2 2022 Aug 12, 2022	BUY	$13.01 - $27.22 $182,400 - $381,624	14,020 Added 33.46%	55,918 $787,000
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $1.94 Million - $2.54 Million	-92,531 Reduced 68.83%	41,898 $1.01 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $2.26 Million - $3.64 Million	134,429 New	134,429 $3.14 Million
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $2.68 Million - $3.71 Million	-65,259 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$36.42 - $57.0 $1.09 Million - $1.71 Million	-29,948 Reduced 31.46%	65,259 $0
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $3.74 Million - $5.02 Million	95,207 New	95,207 $4.61 Million

Others Institutions Holding ACAD

# of Institutions

280

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account